ECP 2023 Final Programme

Monday, 11 Sept Scientific Programme a Monday 44 011 11:10–11:20 Surgically resected adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung – a case series with follow-up Vânia Almeida, Portugal L. Veloso, L. Carvalho 012 11:20–11:30 A comparative analysis of proficiency testing for the biomarkers ALK, ROS1, EGFR, KRAS and BRAF in non-small cell lung cancer (NSCLC) using the IHC,ISH and MolPath methodologies Sabine Merkelbach-Bruse, Germany A. Ryška, D. Jonigk, E. Schuuring, I. Kern, D. Dawodu, K. Ilm, K. Jöhrens 013 11:30–11:40 ROS1 SP384 clone and ROS1 FISH con- cordance in non-small cell lung cancer: a clue for oncogenic driver mutations Claudia Andrea Gomez Gonzalez, Turkey B. Yaman, G. Serin, A. Veral, D. Nart 014 11:40–11:50 Ki-67 and PHH3 score in grading mesothe- lioma: comparison between cytological and surgical specimens Dogu Vuralli Bakkaloglu, Turkey Y. Ozluk KNL-02 Keynote Lecture 12:15–13:00 The Auditorium Chairs: Sean Hynes, Ireland Cynthia Heffron, Ireland Biobanking Pathology Specimens: The bridge bet- ween Science and Medicine Jacqueline James, United Kingdom SY-10 Symposium 14:45–16:45 The Auditorium Digestive Diseases Pathology – GI Pulmonary Pathology Thymic and Mediastinal Pathology Joint Symposium: Thoracic and digestive system neuroendocrine neoplasms: similarities and differences Chairs: Mauro Papotti, Italy Volkan Adsay, Turkey 001 14:45–15:00 The current WHO classification of thoracic NETs and NECs Philipp Ströbel, Germany 002 15:00–15:15 The current WHO classification of digestive system NETs and NECs Volkan Adsay, Turkey 003 15:15–15:30 Small cell carcinoma or large cell neuroen- docrine carcinoma? A nightmare for a pathologist Giuseppe Pelosi, Italy 004 15:30–15:45 Mediastinal tumour with NEC (or NET) morphology – primary (thymic) or metastatic (lung, GI) tumour? Philipp Ströbel, Germany 005 15:45–16:00 DEBATE: NET G3 – does it exist? – YES! – GI pathologist’s perspective Atsuko Kasajima, Germany 006 16:00–16:15 DEBATE: NET G3 – does it exist? – PROBA- BLY – Thoracic pathologist’s perspective Mauro Papotti, Italy 007 16:15–16:45 Panel Discussion: Carcinoids or NETs G1/ G2/G3? Different entities justified by molecular basis or only different names?